Retractable Technologies, Inc. (RVP)
NYSE American · Healthcare · Medical Instruments & Supplies
$0.6952−0.26%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $20.8M
- 52-week range
- $0.60 – $1.14
- 52-week change
- −25.53%
- EPS (trailing)
- −$0.12
Fiscal year to Dec 2025
- Revenue
- $38.3M (+15.78%)
- Net income
- −$12.6M
- Operating margin
- −55.3%
- Diluted EPS
- −$0.43
From the company’s annual report on SEC EDGAR.
About Retractable Technologies, Inc.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Headquarters: Little Elm, United States · 195 employees · retractable.com